Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial

Journal: Nature Medicine

Published: 2020-10-26

DOI: 10.1038/s41591-020-1089-8

Affiliations: 17

Authors: 40

Go to article
Institutions Share
The Ohio State University (OSU), United States of America (USA) 0.23
Leukemia and Lymphoma Society (LLS), United States of America (USA) 0.10
Foundation Medicine, Inc., United States of America (USA) 0.10
Oregon Health and Science University (OHSU), United States of America (USA) 0.08
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA) 0.08
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center), United States of America (USA) 0.05
University of Maryland Medical Center (UMMC), United States of America (USA) 0.05
The University of Chicago (UChicago), United States of America (USA) 0.05
The University of Utah (Utah), United States of America (USA) 0.05
Emory University, United States of America (USA) 0.05
University of California, Los Angeles (UCLA), United States of America (USA) 0.03
University of California, San Francisco (UCSF), United States of America (USA) 0.03
Mayo Clinic, United States of America (USA) 0.03
Mayo Clinic's Campus in Florida, United States of America (USA) 0.03
University of Kansas Medical Center (KUMC), United States of America (USA) 0.03
University of Pittsburgh (Pitt), United States of America (USA) 0.03
The University of North Carolina at Chapel Hill (UNC), United States of America (USA) 0.03

Return